UnicoCell Biomed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	75.07	40.84	9.57	19.9	53.64	130.85
Short-Term Investments	633.14	692.08	518.37	457.38	160.25	10.17
Trading Asset Securities	13.48	13.35	22.3	-	-	-
Cash & Short-Term Investments	721.69	746.27	550.24	477.28	213.89	141.02
Cash Growth	12.27%	35.63%	15.29%	123.15%	51.67%	-39.24%
Accounts Receivable	2.64	3.19	2.81	2.08	1.38	0.4
Other Receivables	21.06	19.37	19.6	18.08	13.47	12.02
Receivables	23.7	22.55	22.41	20.16	14.84	12.42
Inventory	10.31	9.27	9.75	7.5	7.98	7.83
Prepaid Expenses	2.64	3.31	3.66	1.61	1.13	2.04
Other Current Assets	6.61	5.75	6.29	0.24	0.06	-
Total Current Assets	764.94	787.16	592.35	506.8	237.9	163.31
Property, Plant & Equipment	134.1	138.04	152.59	175.89	173.36	131.21
Long-Term Investments	17.26	17.26	29	-	-	-
Other Intangible Assets	0.18	0.26	0.34	0.33	0.36	0.4
Other Long-Term Assets	3.62	3.29	3.61	2.92	2.7	2.8
Total Assets	920.1	946.01	777.89	685.93	414.31	297.71
Accounts Payable	1.01	1.23	1.97	0.11	0.91	0.08
Current Portion of Leases	6.38	6.35	6.22	6.09	5.93	8.95
Current Unearned Revenue	0.41	1.1	6.62	0.02	1.52	-
Other Current Liabilities	11.06	12.06	12.32	10.68	8.18	12.34
Total Current Liabilities	18.86	20.73	27.13	16.9	16.54	21.37
Long-Term Leases	54.06	55.67	62.02	68.24	60.66	12.63
Other Long-Term Liabilities	4.18	4.18	4.13	4.35	3.26	0.71
Total Liabilities	77.1	80.58	93.28	89.49	80.46	34.71
Common Stock	636.37	636.37	584.11	556.85	423.61	377.75
Additional Paid-In Capital	961.66	961.01	705.87	551.89	338.43	222.29
Retained Earnings	-743.3	-720.2	-605.37	-512.29	-428.19	-337.03
Comprehensive Income & Other	-11.74	-11.74	-	-	-	-
Shareholders' Equity	843	865.44	684.61	596.44	333.85	263.01
Total Liabilities & Equity	920.1	946.01	777.89	685.93	414.31	297.71
Total Debt	60.44	62.02	68.24	74.33	66.59	21.58
Net Cash (Debt)	661.24	684.25	482.01	402.95	147.3	119.44
Net Cash Growth	14.78%	41.96%	19.62%	173.56%	23.32%	-39.71%
Net Cash Per Share	10.66	11.24	8.40	7.49	3.55	3.17
Filing Date Shares Outstanding	63.64	63.64	58.41	55.69	42.36	37.78
Total Common Shares Outstanding	63.64	63.64	58.41	55.69	42.36	37.78
Working Capital	746.09	766.43	565.22	489.9	221.36	141.94
Book Value Per Share	13.25	13.60	11.72	10.71	7.88	6.96
Tangible Book Value	842.82	865.18	684.27	596.12	333.5	262.61
Tangible Book Value Per Share	13.24	13.60	11.71	10.71	7.87	6.95
Machinery	72.25	73.95	70	67.02	65.56	60.92
Construction In Progress	-	-	-	-	-	68.3
Leasehold Improvements	99.39	99.39	98.28	97.5	93.25	16.35